Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Capecitabine and Radiotherapy in Locally Advanced Rectal Cancer
NCT00671645Phase 2Terminated
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Austrian Breast and Colorectal Cancer Study Group. Started Jul 2008; status: terminated.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00671645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00671645.